Association of RASis and HMG-CoA reductase inhibitors with clinical manifestations in coronavirus disease 2019 patients: Results from the Khorshid Coronavirus Disease Cohort Study

Association of RASis and HMG-CoA reductase inhibitors with clinical manifestations in coronavirus disease 2019 patients: Results from the Khorshid Coronavirus Disease Cohort Study

Background: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEinhs) may deteriorate or improve the clinical manifestations in severe acute respiratory syndrome coronavirus 2 infection. A comparative, cross-sectional study was conducted to evaluate the associati...

Full description

Bibliographic Details
Main Authors: Bijan Iraj, Amir Reza Moravejolahkami, Ramin Sami, Maryam Riahinezhad, Zahra Tasdighi, Arash Toghyani, Nastaran Sadat Hosseini, Fatemeh Dehghan Niri, Gholamreza Askari
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Research in Medical Sciences
Subjects:
coronavirus disease 2019
critical care
hydroxymethylglutaryl-coa reductase inhibitors
renin–angiotensin system
severe acute respiratory syndrome coronavirus 2
x-ray computed tomography
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2023;volume=28;issue=1;spage=15;epage=15;aulast=Iraj

Similar Items

Similar Items